+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

Results for tag: "Etanercept"

From
Anti-Rheumatics Market - Global Forecast 2025-2032 - Product Thumbnail Image

Anti-Rheumatics Market - Global Forecast 2025-2032

  • Report
  • October 2025
  • 187 Pages
  • Global
From
Psoriasis Biosimilar Market - Global Forecast 2025-2030 - Product Thumbnail Image

Psoriasis Biosimilar Market - Global Forecast 2025-2030

  • Report
  • August 2025
  • 197 Pages
  • Global
From
From
Axial Spondyloarthritis Market - Global Forecast 2025-2032 - Product Thumbnail Image

Axial Spondyloarthritis Market - Global Forecast 2025-2032

  • Report
  • October 2025
  • 197 Pages
  • Global
From
TNF Inhibitors Market - Global Forecast 2025-2032 - Product Thumbnail Image

TNF Inhibitors Market - Global Forecast 2025-2032

  • Report
  • October 2025
  • 192 Pages
  • Global
From
From
From
From
From
Anti-Inflammatory Biologics Market Report 2025 - Product Thumbnail Image

Anti-Inflammatory Biologics Market Report 2025

  • Report
  • October 2025
  • 250 Pages
  • Global
From
Psoriasis Biosimilars Market Report 2025 - Product Thumbnail Image

Psoriasis Biosimilars Market Report 2025

  • Report
  • September 2025
  • 250 Pages
  • Global
From
From
From
From
From
Anti-Inflammatory Drugs - Global Strategic Business Report - Product Thumbnail Image

Anti-Inflammatory Drugs - Global Strategic Business Report

  • Report
  • November 2025
  • 488 Pages
  • Global
From
Biosimilar Monoclonal Antibody - Global Strategic Business Report - Product Thumbnail Image

Biosimilar Monoclonal Antibody - Global Strategic Business Report

  • Report
  • November 2025
  • 235 Pages
  • Global
From
Autoimmune Drugs - Global Strategic Business Report - Product Thumbnail Image

Autoimmune Drugs - Global Strategic Business Report

  • Report
  • November 2025
  • 287 Pages
  • Global
From
Loading Indicator

Etanercept is a biologic drug used to treat immune disorders such as rheumatoid arthritis, psoriatic arthritis, ankylosing spondylitis, and plaque psoriasis. It is a recombinant fusion protein that works by blocking the action of tumor necrosis factor (TNF), a protein involved in inflammation. Etanercept is administered by subcutaneous injection and is available in both brand name and generic forms. Etanercept is a widely used drug in the treatment of immune disorders, and is often prescribed in combination with other medications. It is generally well tolerated, with the most common side effects being injection site reactions, headache, and upper respiratory tract infections. The etanercept market is highly competitive, with several major players. These include Amgen, Pfizer, AbbVie, and Johnson & Johnson. Other companies in the market include Biogen, Merck, and Novartis. Show Less Read more